Introduction
Docosahexaenoic acid (DHA, and arachidonic acid (AA, are both important for development of the central nervous system in mammals (Crawford et al, 1976; Neuringer et al, 1984 , Anderson et al, 1990 . Since most af¯uent diets contain little n-3 fatty acids , these fatty acids have been studied in relation to brain and visual maturation . DHA is present in high concentrations in cerebral gray matter (O'Brien et al, 1964) and in even greater concentrations in the photoreceptors of the retina (Anderson, 1970; Tinoco et al, 1977) . Most DHA accumulates during the last trimester of pregnancy (Clandinin et al, 1980b; Martinez, 1992) , but even during the initial months after birth, a considerable amount of this n-3 fatty acid is incorporated in the central nervous system (Clandinin et al, 1980a; Farquharson et al, 1992; Martinez, 1992; Makrides et al, 1994) . New-born babies have a limited capacity for elongation and desaturation of a-linolenic acid (18:3n-3) to DHA (Clandinin et al, 1980a; Hoffman & Uauy, 1992; Makrides et al, 1995; Carlson et al, 1996; Salem et al, 1996) and infants are therefore probably dependent on dietary supply. In contrast to most formulas, all human milk contains DHA and AA, but the concentration of these very long-chain fatty acids is quite variable. The fatty acid pattern of human milk lipids is highly in¯uenced by fatty acid composition of maternal diet, as demonstrated by Thiemich in 1899 (Thiemich 1899) and subsequently con®rmed in several other studies (Insull et al, 1959; Harris et al, 1984; Innis & Kuhnlein, 1988; Henderson et al, 1992) . Innis & Kuhnlein (1988) found that Inuit women in Canada, with large amounts of very long-chain n-3 fatty acids in their diet, had higher levels of DHA and eicosapentaenoic acid (EPA, in their milk compared to women from Vancouver.
When lactating mothers were supplemented with ®sh oil, the amount of n-3 fatty acids in breast milk increased (Harris et al, 1984; Henderson et al, 1992) . It is a Norwegian tradition to take supplements of cod liver oil. Supplementation with cod liver oil probably in¯uences the fatty acid composition of breast milk, and we examined how different dosages of cod liver oil affect the fatty acid pattern. Since an increase of very long-chain polyunsaturated fatty acids (PUFA) may increase lipid peroxidation (Drevon et al, 1995) , we also examined the levels of vitamin E in mothers' milk. In addition, we examined the mothers' diet by a food frequency questionnaire because the dietary intake of fatty acids provides 50 ± 100 g daily. Our report is thus the ®rst study on effects of cod liver oil consumption and general food intake on breast milk fatty acid composition.
Materials and methods

Study design and data collection
Twenty-eight healthy, lactating women were recruited at child health care centers during preventive consultations 3 ± 8 weeks after they had given birth. All subjects signed an informed consent, and the study was approved by the Local Ethics Committee. Twenty-two women completed the study. One participant did not return the food frequency questionnaire, three women did not deliver breast milk samples, and two subjects felt discomfort taking the oil as a supplement. Data on height and weight were selfreported and taken from the food frequency questionnaire.
The supplementation period was 14 days, between 3 and 8 weeks post partum. The mothers were randomly allocated to four different groups; group 1 (n 6) had no supplementation; group 2 (n 5) received 2.5 ml cod liver oil daily; group 3 (n 5) had 5 ml/d; and group 4 (n 6) was supplemented with 10 ml cod liver oil daily. Cod liver oil contained 7.7 g of EPA, 10.2 g of DHA and 22.9 g of total n-3 fatty acids per 100 ml ( Table 1 ). The vitamin content was adjusted so that all the supplemented women received the same amount of vitamins A and D daily: 1 mg vitamin A, 10 mg vitamin D and 4.6 ± 18.4 mg vitamin E. The cod liver oil was taken every morning from day 1.
Maternal diet analysis
All participants ®lled in a self-administered food frequency questionnaire (Nes et al, 1992 ) that comprised approximately 180 food items and covered the whole diet. The forms were designed for optical mark reading, and all calculations were computerized. The questionnaire has been validated by comparing it to weighed diet records in a group of elderly women (Nes et al, 1992) and in a group of dermatological outpatients by 48-hour recall interviews (Solvoll et al, 1993) . Moreover, the food frequency questionnaire was validated against the fatty acid pattern of plasma phospholipids in 579 subjects, demonstrating that the questionnaire may be used for estimation of dietary intake of very long-chain n-3 fatty acids (Frost Andersen et al, 1996) . The mothers were asked to continue their habitual diet during the study period.
Sample collection
Venous blood samples from the mothers were taken day 0 and day 14. Samples were collected in EDTA-containing vacuum-tubes and plasma was kept at 7 70 C under nitrogen.
Milk samples of 20 ± 40 ml were collected on days 0, 1, 2, 4, 7, 10 and 14. The samples were taken from a morning feed (never the ®rst one), 3 ± 5 minutes after the baby started suckling. The milk was expressed manually and collected in plastic cups with 1 ml EDTA (74 mg/ml) and 0.1 ml BHT (30 mg/ml) (Sigma Chemical Co., St Louis, MO, USA). The mothers were instructed to use no ointments or oils on their breasts during the study. The samples were immediately put in a home freezer and kept at 7 20 C until day 14 of the study. The samples were then thawed, dispensed and gassed with nitrogen before freezing at 7 70 C.
Sample analysis
The content of fatty acids in plasma phospholipids was determined by gas ± liquid chromatography. To 0.6 ml plasma, were added 120 mg internal standard (phosphatidylcholine-diheptadecanoyl 17:0), Sigma) and 2 ml ethanol plus 1 ml water. After shaking, 1 ml heptane was added and whirl-mixed for 30 s. After centrifugation, the heptane phase was applied on an aminopropyl solid-phase column (Waters) equilibrated with 2 6 2 ml hexane. The column was washed with 4 ml chloroform : isopropanol (2:1; v/v) and 4 ml 2% acetic acid in diethyl ether, before the phospholipids were eluted with 2 ml methanol. After evaporation, the samples were saponi®ed for 10 min at 65 C in 1.2 ml 0.5 N NaOH in methanol. After cooling, the fatty acids were methylated by adding 1.5 ml 20% BF 3 in methanol (Merck, Hohenbrunn, Germany), and heated for 20 min at 65 C. The methyl esters were extracted in 1.5 ml heptane and separated on a fused silica wall coated capillary column (Supelcowax-10, 30 m 6 0.32 mm, ®lm thickness 0.25 mm, from Supelco Inc., Bellefonte, PA USA) in a Perkin Elmer 8400 gas chromatograph with a¯ame-ionization detector and a programmable temperature vaporizer injector. The samples were injected using an autosampler (Perkin Elmer AS-3000). The carrier gas was helium at ā ow rate of 1.6 ml/min. The injector and detector temperatures were 275 C. The column temperature was 70 C for 2 min, increased to 180 C at a rate of 30 C/min then increased to 235 C at a rate of 1 C/min. Peak areas were determined by Turbochrome Integrator system (Perkin Elmer) and a Brick 9002 personal computer. Identi®cation of major peaks was done by comparing the retention time with standard fatty acid methyl esters obtained from Sigma. A test plasma was analyzed with every new series of plasma samples to assure reproducibility.
The fatty acid pattern in breast milk was also determined by gas ± liquid chromatography (Clark & Roche, 1990) . To 100 ml of milk was added 100 ml of tritricosanoin (C23:0 TG, Sigma) dissolved in benzene (2 mg/ml), as internal standard. The samples were extracted with 2 ml methanol : benzene (4:1 v/v) before methylation by addition of 200 ml acetyl chloride followed by heating for 1 h at 100 C. The samples were cooled, and 5 ml of 6% potassium carbonate (w/v) and 2 ml of benzene were added. After centrifugation, an aliquot of the upper phase containing the methyl esters was separated by gas ± liquid chromatography under the same conditions as for the plasma samples. One test milk was analyzed with every new series of milk samples to validate reproducibility. Total lipid concentration in milk was calculated based on the peak areas of methyl esters relative to the internal standard (Clark & Roche, 1990) . The content of total tocopherol in breast milk and plasma was determined by HPLC according to a method developed by T. Gundersen. The absorbance was measured by a spectrophotometer (Beckman DU 640), and the concentration was calculated by the formula mM a-tocopherol absorbance 6 10 000)/(430.699 6 E 1 ) (l 294, E 1 72). Proper aliquots were diluted with a 1% (w/v) albumin solution in PBS buffer (80 g NaCl, 2 g KCl, 14.4 g Na 2 HPO 4 and 2.4 g KH 2 PO 4 dissolved in 800 ml water) to obtain concentrations of tocopherol in the range 1 ± 40 mmol/l. To 300 ml of cold milk or plasma was added, 900 ml of cold absolute 2-propanol. The mixture was vortexed and centrifuged at 3000 g (Heraeus megafuge 1.0 R) for 15 min at 4 C before the samples were loaded into the cooled autoinjector (4 C) (Shimadzu SIL-10). A 20 ml aliquot was injected in the analytical column (250 6 4.6 mm ID Supelcosil LC-8 with a 20 6 4.6 mm Pelliguard LC-8 guard column, Supelco), using a mobile phase (96.4% acetonitrile, 3.5% methyl-tertbutyl ether, 0.1% double-distilled water) and detected by¯uorescence (Shimadzu, RF-10 detector). Excitation wavelength was 294 nm, emission wavelength was 330 nm.
Statistical analysis
Results are presented as medians with total range in parentheses and nonparametric tests were applied owing to the small number of individuals in each group and to lack of normal distribution of the data. Comparisons of the fatty acid pattern before and after the study were performed by Wilcoxon signed rank test, whereas comparisons between the groups were done by Cuzick's test, a nonparametric trend test. To evaluate correlations, Spearman test was used. P-values 0.05 were considered statistically signi®cant. StatView 4.51 was used for statistical analysis. Fatty acids in breast milk IB Helland et al
Results
Subjects
The median age of the mothers was 29 (21 ± 38) years, their height was 1.70 (1.52 ± 1.78) m and their body weight was 66 (56 ± 88) kg, resulting in body mass index (BMI) of 24.1 (18.8 ± 38.1) kg/m 2 . None of the mothers were daily smokers and none of them had taken supplements of o-3 fatty acids regularly after giving birth or for the 6 weeks previous to the study.
Maternal diet
The daily energy intake was 8.26 (3.39 ± 13.42) MJ (Table  2) . Fat accounted for 30.8 (18.0 ± 38.5)% of the energy, protein for 17.4 (8.3 ± 21.1)% and carbohydrates made up 51.2 (44.7 ± 73.7)%. Nine mothers (41%) exceeded the national recommended maximum of 30% energy intake from fat, and four mothers (18%) had more than the recommended 10% energy derived from sugar. The median daily intakes of DHA, EPA and AA were 0.29 (0.03 ± 1.32) g, 0.16 (0.01 ± 1.05) g and 0.11 (0.04 ± 0.20) g, respectively. Saturated fatty acids accounted for 38.4 (33.6 ± 46.0)% of total fat intake, monoenes for 34.8 (30.3 ± 38.0)% and polyenes made up 18.3 (14.6 ± 25.6)%.
Fatty acid pattern of maternal plasma phospholipids
There was an increase in DHA in all the supplemented groups, but the increase was signi®cant only in the group receiving 10 ml cod liver oil daily (Table 3) . EPA also increased in all groups, but increased signi®cantly only in groups 1 and 4. The sum of n-3 fatty acids increased in group 1 and 4, and the ratio n-6/n-3 fatty acids decreased signi®cantly in group 4. When the baseline value was subtracted from the value measured after 14 days for all subjects and compared with a linear trend test related to dose of cod liver oil, we found signi®cant differences for linoleic acid (18:2n-6), a-linolenic acid (18:3n-3), dihomog-linolenic acid (20:3n-6) and DHA.
Fatty acid composition of human milk
There was a signi®cant increase of the concentration of DHA in groups supplemented with 2.5, 5 and 10 ml of cod liver oil during 14 days of supplementation (Table 4 ). The content of EPA also increased signi®cantly in the groups supplemented with 5 and 10 ml of cod liver oil. Moreover, in group 4 there was a signi®cant increase of docosapentaenoic acid (DPA, 22:5n-3). The amount of AA did not change in any of the supplemented groups. The sum of n-3 fatty acids increased signi®cantly in group 4, and the ratio n-6/n-3 fatty acids decreased signi®cantly in group 1. When the baseline value was subtracted from the value measured after 14 days for all individuals and compared with a linear trend test related to dose of cod liver oil, we found signi®cant differences for stearic acid (18:0), AA, EPA, DPA, DHA and the sum of n-3 fatty acids. This means that there is a relationship between intake of cod liver oil and the amount of these fatty acids in breast milk.
The time course for the percentage of DHA, DPA, EPA and AA related to total fatty acids in breast milk is illustrated in Figure 1 . The area under the curve for DHA, DPA and EPA was enhanced signi®cantly in relation to the increasing intake of cod liver oil. The increase in the Relation between intake and concentration of fatty acids in maternal plasma and breast milk When total intake of DHA (diet plus supplementation) was adjusted to BMI, there were signi®cant correlations between intake and concentrations in plasma phospholipids (r 0.49, P 0.02) and breast milk (r 0.45, P 0.04). For EPA, the correlation was signi®cant only for breast milk (r 0.58, P 0.008), not for plasma phospholipids (r 0.40, P 0.06). There were signi®cant correlations between the amounts of DHA or EPA in plasma phospholipids and the amount of DHA or EPA in breast milk (r 0.66, P 0.003; r 0.65, P 0.003, respectively). There was no signi®cant correlation between AA in plasma and breast milk.
Concentration of tocopherol in human milk and plasma
The concentration of total tocopherol was similar in all groups; 10.1 (3.9 ± 17.7) mmol/l in human milk (n 22) and 21.7 (16.8 ± 30.2) mmol/l in maternal plasma (n 21) at baseline, and 8.0 (4.2 ± 22.1) mmol/l in milk (n 22) and 20.0 (15.0 ± 28.6) mmol/l in plasma (n 21) after 14 days of supplementation (Table 5 ). There was no signi®cant difference between the groups, and no change in the concentration of total tocopherol in breast milk and plasma during the supplementation period. There was no change in the ratio tocopherol/lipids in breast milk during the supplementation period (Table 5) . There was no correlation between the concentration of tocopherol in maternal plasma and breast milk.
Discussion
Our data show that supplementation of lactating mothers with even small amounts of cod liver oil promotes increased DHA concentration in breast milk. Also, the amount of EPA in breast milk increased in all the supplemented groups, but increased signi®cantly only for those receiving 5 and 10 ml cod liver oil daily. This means that an intake of 2.5 ml/d of cod liver oil promotes a signi®cant increase in the supply of DHA for the suckling infant during the ®rst months after birth (Figure 1) . From Figure 1 The content of (A) DHA, (B) EPA, (C) DPA and (D) AA (wt%) in breast milk during 14 days of cod liver oil supplementation. Group 1 did not receive any supplement, group 2 had 2.5 ml, group 3 had 5 ml and group 4 had 10 ml cod liver oil each day. Values are expressed as medians. DHA increased signi®cantly in groups 2, 3 and 4 after 14 days of supplementation (P 0.05, Wilcoxon signed rank test). EPA increased signi®cantly in groups 3 and 4 (P 0.05); DPA increased in group 4 (P 0.05) and AA decreased signi®cantly in group 1 (P 0.05).
Fatty acids in breast milk IB Helland et al evaluation of individual breast milk samples, we observed that PUFA patterns undergo large daily variations (data not shown). Single doses of foods rich in DHA caused 2 ± 3-fold increase in DHA concentration in mothers' milk within 1 ± 2 days after intake. Our group data also demonstrate that there was increased DHA as well as EPA in breast milk within 2 ± 4 days after start of supplementation with 10 ml of cod liver oil (Figure 1) . Henderson et al (1992) have reported that the very long-chain n-3 fatty acids increased most rapidly between days 2 and 7, and remained fairly constant after 7 days of ®sh oil supplementation.
We observed no change in the levels of AA in breast milk of the supplemented mothers (Figure 1 ), as reported in other studies using ®sh oil supplements (Harris et al, 1984; Henderson et al, 1992) or single cell oil with DHA only (Makrides et al, 1996) . Linear trend test on differences between day 14 and baseline values showed a positive relationship between AA content in breast milk and intake of cod liver oil, but the trend test failed to show any relationship between area under the curve for AA and intake of cod liver oil. This is especially important since two studies of premature infants have suggested that AA is an important nutrient for optimal growth during early life (Koletzko & Braun, 1991; Carlson et al, 1992) .
Our data also show that the level of DHA in breast milk is proportional to the amount of DHA in maternal plasma phospholipids, and the DHA/BMI dose correlated with breast milk DHA and DHA in plasma phospholipids. This is in accordance with a report from Makrides et al (1996) . However, we did not ®nd any correlation between dietary intake of DHA and levels in breast milk before the supplementation period (data not shown). This could mean that direct correlation between fatty acids in the diet and the breast milk occurs only above a certain intake. In our present study, lactating mothers had higher levels of DHA and EPA in their breast milk (0.36 (0.15 ± 1.56) wt%, n 22; 0.15 (0.07 ± 0.46) wt%, n 22) than found in other studies from the United States and Australia (Harris et al, 1984; Makrides et al, 1996) . This probably re¯ects a relatively high intake of ®sh and ®sh products in the Norwegian diet. The intake of DHA was 0.29 (0.03 ± 1.3) g/d in our study, and the intake of EPA was 0.16 (0.01 ± 1.05) g/d, as compared to 0.1 AE 0.1 g/d of DHA and 0.03 AE 0.04 g/d of EPA in Henderson's study (Henderson et al, 1992) .
No changes in the concentration of tocopherol were noted, neither in maternal plasma nor in breast milk (Table 5 ). This suggests that vitamin E de®ciency is not induced by cod liver oil consumption. The level of plasma tocopherol in our population of lactating mothers was in the same range as in Norwegian dermatological outpatients (Bjorneboe et al, 1987) .
In a recent study, the concentration of a-tocopherol in human milk was reported to be considerably lower than in our study, whereas plasma levels were higher (Can®eld et al, 1997) . We have measured total tocopherol (a-gtocopherol), and in breast milk there seems to be relatively more g-tocopherol than in plasma (data not shown). This could explain the observed higher levels of tocopherol in our samples than reported by Can®eld et al (1997) .
In conclusion, our study shows that supplementation with cod liver oil during lactation increases the content of DHA in breast milk in a dose-dependent way. This may be of practical importance for women and their infants, since mothers may lose DHA during several pregnancies and infants need large amounts of DHA for development of the central nervous system (Clandinin et al, 1980a; Farquharson et al, 1992; Hoffman & Uauy, 1992; Makrides et al, 1994; Makrides et al, 1995; Carlson et al, 1996) .
